What does 'integration' actually mean in ketamine assisted psychotherapy?

Integration is the structured work of processing and making meaning from a ketamine or Spravato session in the hours, days, and weeks after it happens, not the dosing session itself. It is a specific term inside the ketamine assisted psychotherapy (KAP) literature, usually paired with a preparation phase that happens before dosing, and neither phase is the same thing as the medically supervised dose.

The idea that ketamine could open a window for psychotherapeutic work, rather than just sedate or dissociate a patient, goes back further than most people assume. Iranian psychiatrists Khorramzadeh and Lotfy were among the first to describe this in a clinical journal, reporting in 1973 that subanesthetic ketamine acted as an abreactive agent that helped roughly 100 psychiatric inpatients process difficult material during sessions. Researchers in the Soviet Union and later Russia, led by Evgeny Krupitsky, built on this through the 1980s and 90s with what they called ketamine psychedelic therapy for alcoholism, deliberately pairing ketamine sessions with structured psychotherapy rather than administering the drug on its own.

A 2022 concept analysis in Frontiers in Psychology, reviewing how the wider psychedelic therapy field uses the word, defined integration as the process of bringing separate elements together into a whole and anchoring them into daily life, a useful way to separate it from simply feeling better for a few days after a dose. The modern KAP field took shape in the 2010s, when clinicians including psychiatrist Phil Wolfson and psychologist Raquel Bennett began building formal training models around a preparation, dosing, and integration structure, and the American Society of Ketamine Physicians, Psychotherapists and Practitioners, a professional group founded in 2016, has since published consensus standards describing team based, integrated care as part of a complete model rather than an optional add on. None of that means every ketamine or Spravato appointment includes it. A standard infusion visit or psychiatric Spravato appointment can be, and often is, just the dose and the monitoring window the law requires, with no integration attached at all.

Does the FDA require psychotherapy after a ketamine or Spravato session?

No. The FDA's approval of Spravato (esketamine) requires that patients be monitored by a healthcare provider for at least two hours after each dose, inside a certified REMS healthcare setting, and that it be used in conjunction with an oral antidepressant. Nowhere in the approved FDA prescribing information is psychotherapy, integration, or any talk therapy component required.

What the label does require is specific and medical. During the two hour monitoring window, a provider checks respiratory status with pulse oximetry, takes blood pressure at intervals, and confirms the patient is clinically stable before they can leave, since Spravato must never be dispensed for home use. The label's boxed warning covers:

Spravato was approved for treatment resistant depression in adults in 2019, and for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior in 2020, in both cases specifically alongside an oral antidepressant, not alongside psychotherapy. What is medically required, the dose and the monitoring, is exactly what a clinic is built to deliver in a couple of hours. What is not required, the preparation beforehand and the integration work afterward, is left to whatever the patient arranges separately. Epic Journey Recovery's ketamine therapy coordination work sits in that second category. It does not replace the dosing session, which is handled by a contracted, licensed medical provider, it is built around it.

What does the research say about outcomes with integration support versus ketamine alone?

The honest answer is that the evidence is preliminary and genuinely mixed, not settled in either direction. A handful of controlled trials, mostly in substance use disorders, show a measurable benefit from adding structured therapy to ketamine, while several recent systematic reviews focused on depression conclude there is not yet enough rigorous, controlled evidence to say psychotherapy reliably improves on ketamine alone.

On the more cautious side:

The stronger positive evidence sits with alcohol use disorder. In a double-blind, placebo-controlled trial, researchers randomized 96 people with severe alcohol use disorder to ketamine or saline, each paired with either psychological therapy or alcohol education. The group that received ketamine plus psychological therapy stayed abstinent 87 percent of days over six months, more than twice as likely to remain fully abstinent as the placebo group. That is one of the few trials in this field that actually isolated the therapy variable with a real control group, worth naming as the exception rather than treated as proof the same pattern holds for depression, anxiety, or trauma.

Why does ketamine's antidepressant effect tend to fade without follow-up support?

Ketamine's antidepressant effect is real but frequently short-lived when the dosing itself is the entire treatment. In one of the field's most cited studies of repeated IV infusions for treatment-resistant depression, patients who responded relapsed after an average of about 18 days once the infusions stopped.

The theory behind integration is that ketamine opens a short window of neuroplasticity, and what a person does with that window, practically and psychologically, matters for whether change sticks. That is a plausible mechanism, but it remains a theory, not something a controlled trial has proven causes durability. The closest evidence comes from a small, Yale-led proof-of-concept trial, where patients who had responded to a course of IV ketamine were randomized to cognitive behavioral therapy or usual care for the following weeks, and the CBT group showed preliminary signs of sustaining their improvement longer. A larger follow-up trial, CBT-ENDURE, later found that adding 16 weeks of CBT after esketamine produced greater improvement in suicidal ideation and depression severity than esketamine plus usual care alone, in patients hospitalized with major depression.

It is worth being precise about what these two trials actually tested. They studied structured cognitive behavioral therapy layered on after ketamine or esketamine for relapse prevention, which is not identical to integration in the meaning-making sense used in the KAP literature. But both point at the same structural idea from different angles, that whatever happens, or does not happen, in the weeks after a dosing session appears to matter for how long the benefit lasts. Neither trial is large enough to be the final word, and both research teams describe their findings as needing replication.

Is ketamine safe to use without medical supervision, and does that matter for integration too?

No, ketamine carries real dissociative effects and documented abuse potential, which is exactly why the DEA placed it in Schedule III of the Controlled Substances Act in 1999 and why Spravato's FDA label carries a boxed warning for sedation, dissociation, and abuse and misuse. That history matters for integration too, because the entire model depends on the dose itself being administered in a licensed, medically supervised setting. Integration is not a substitute for that supervision, it is additional structure built around it.

The DEA's own 1999 scheduling decision cited more than 775 reports of ketamine diversion or abuse received since 1992, and more than 568 law enforcement encounters involving people who sold, possessed, or were under the influence of the drug. NIDA describes ketamine as a dissociative drug that blocks NMDA receptors and disconnects users from their body and surroundings, and notes that unsupervised, recreational use is linked to bladder and urinary tract damage, memory loss, worsened depression and anxiety, and withdrawal symptoms with regular use. None of that describes what happens in a licensed clinical setting under a contracted provider's supervision, but it is the reason that setting, and the credentials of whoever is running it, are not a detail to skip past.

This is also why Epic Journey Recovery does not administer, prescribe, or dose ketamine or Spravato itself. It coordinates treatment through contracted, licensed medical providers in Orange County who handle the clinical dosing and the monitoring the FDA requires, while the coaching team focuses on the structure around it, before and after.

What does structured integration support actually look like in practice?

In the KAP literature, integration usually means scheduled conversations in the days and weeks after a session where a therapist or coach helps a person work through whatever came up during dosing, an emotional release, a memory, a shift in perspective, and connect it to something concrete they change in daily life. It is typically paired with a preparation phase before the session that sets an intention and lowers anxiety about the experience itself, so the work spans well before and after the appointment, not just the appointment.

In practice, that structure commonly includes:

None of that is clinical psychotherapy performed during the dosing appointment itself, which remains a separate, licensed service. This is the part of the process Epic Journey Recovery is built around. Epic Journey is concierge recovery coaching based in Newport Beach, working in person across Orange County and virtually nationwide. It coordinates ketamine therapy, IV, intramuscular, and Spravato, along with TMS, through contracted, licensed local providers. Epic Journey does not administer these treatments and does not run the clinical dosing or the psychotherapy integration session itself, that is the contracted provider's work. What its team of about 12, coaches, holistic practitioners, a functional medicine provider, a neurologist, a psychiatrist, and licensed therapists, focuses on is the preparation beforehand, accountability in between, and the daily life integration work around those clinical sessions.

Why does this support gap get skipped so often?

Because it is optional, and optional, uncovered work is the first thing to get cut when cost, time, or convenience is a factor. Neither the FDA label nor most insurance plans require or pay for preparation or integration around a ketamine or Spravato session, only the dose and its mandated monitoring window are structured by regulation, so the surrounding support depends entirely on what a patient arranges and pays for separately.

This is not a new problem in behavioral health, it is a familiar one wearing a new outfit. The same gap shows up after residential treatment ends and a person goes home without a structured aftercare plan, and it shows up here, after a ketamine or Spravato session ends and a person leaves the clinic with no structured plan for what comes next. In both cases, the highest-intensity, most supervised part of care is also the shortest and most visible part, while the longer stretch of ordinary days where change actually gets practiced, or abandoned, draws far less structure and far less funding.

Epic Journey Recovery works with people during that stretch. It is not a treatment facility, has no beds, and is not licensed treatment, it is cash-pay concierge coaching, so it can build a schedule around a client's actual life rather than a facility's calendar. Most engagements start with a 90 day core period where the full team works intensively, many people continue up to about six months, and a number of clients taper down to roughly one session a week with whoever on the team they connected with most. Founder Preston Durnford has been sober more than a decade, has spent over 11 years owning and operating treatment centers, and has personally led more than 500 interventions. If you are weighing whether to build structured support around a ketamine or Spravato treatment plan, you can book a free consult to talk through what that could look like.

Questions people ask

Is ketamine assisted psychotherapy the same thing as a Spravato appointment?

Not necessarily. Spravato's FDA label only requires a two hour monitoring window and an oral antidepressant, so a Spravato visit can be just the dosing session. Ketamine assisted psychotherapy (KAP) is a specific model that deliberately wraps preparation and integration therapy around dosing, whether the drug is IV ketamine, IM ketamine, or Spravato.

Does insurance cover ketamine integration therapy?

Generally no. Spravato's medically supervised dosing and monitoring may be billable through insurance in some cases, but the preparation and integration work around it, along with most IV or IM ketamine itself, is typically a separate cash pay service, which is a major reason it gets skipped.

How strong is the research showing integration improves ketamine outcomes?

It is preliminary and mixed. Some controlled trials, especially for alcohol use disorder, show added benefit from combining ketamine with structured therapy, but recent systematic reviews of depression focused studies say there is not yet enough rigorous, controlled evidence to say psychotherapy reliably improves on ketamine alone.

Is ketamine dangerous or addictive?

Ketamine has real dissociative effects and documented abuse potential, which is why the DEA classifies it as a Schedule III controlled substance and why Spravato carries an FDA boxed warning for sedation, dissociation, and abuse and misuse. That risk is exactly why dosing sessions require licensed medical supervision.

What does Epic Journey Recovery do around ketamine and Spravato therapy?

Epic Journey is concierge recovery coaching based in Newport Beach, not a treatment facility. It coordinates ketamine and Spravato treatment through contracted, licensed local providers in Orange County and builds the preparation, accountability, and integration structure around those sessions, in person across Orange County and virtually nationwide.

Sources